Add to Watchlist Create Alerts

Delayed Last Update

Volume

Stocks in play: Avivagen Inc

Baystreet.ca - Baystreet - Fri Sep 16, 2022

Has announced its unaudited financial results for the third quarter of 2022. The Company reported net revenues of $48,606 and a comprehensive loss of $(1,901,453) for the three-month period ended July 31, 2022. This compares to revenues of $878,811 and a comprehensive loss of $(1,209,130) in the three-month period ended July 31, 2021. Avivagen Inc shares V.VIV are trading unchanged at $0.17.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

Premarket: U.S. dollar near five-month highs ahead of Fed policy decision

The close: Major indexes fall after wage data; cannabis shares surge on U.S. regulatory move

The close: Stocks higher as investors focus on Fed moves

The close: Major North American indexes rise as megacap tech stocks rally

Why this money manager is venturing back into emerging markets and adding more U.S. tech

How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy

report on business

Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders

The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market